logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

Noah Holdings (06686) spent approximately $44.84 million to repurchase 225,730 shares on March 31st.

date
21:10 01/04/2026
avatar
GMT Eight
Noah Holdings (06686) announced that it spent approximately $448,400 to repurchase 225,730 shares on March 31, 2026.
Noah Holdings (06686) announced a buyback of approximately $448,400 to repurchase 22.573 million shares on March 31, 2026.
Related Articles
US Stock Market Move | NIKE, Inc. Class B (NKE.US) plunged more than 14%. Sales in the Greater China region for the fourth quarter are expected to decline by 20%.
HK Stock
REMEGEN (09995): The National Medical Products Administration approved the clinical trial of the injection drug RC288, a bispecific antibody-drug conjugate (bispecific ADC).
HK Stock
Centalcon Holding (03321): Executive Director Song Yanyang has been reassigned as the Vice Chairman of the Board.
US Stock Market Move | NIKE, Inc. Class B (NKE.US) plunged more than 14%. Sales in the Greater China region for the fourth quarter are expected to decline by 20%.
REMEGEN (09995): The National Medical Products Administration approved the clinical trial of the injection drug RC288, a bispecific antibody-drug conjugate (bispecific ADC).
HK Stock
Centalcon Holding (03321): Executive Director Song Yanyang has been reassigned as the Vice Chairman of the Board.
HK Stock
RECOMMEND
The “Google Panic” In Memory Stocks: New Cycle Dynamics Beneath Technological Headlines
The “Google Panic” In Memory Stocks: New Cycle Dynamics Beneath Technological Headlines
icon
01/04/2026
Price Increase Cycle Begins, Semiconductor Industry Enters New Stage Of Rising Volume And Value
Price Increase Cycle Begins, Semiconductor Industry Enters New Stage Of Rising Volume And Value
icon
01/04/2026
When Will Hong Kong Stocks Reach Their Low Point?
When Will Hong Kong Stocks Reach Their Low Point?
icon
01/04/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.